Journal article
Time to reconsider the role of ribavirin in Lassa fever
- Abstract:
- Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation of ribavirin is therefore needed.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Supplementary materials, 38.9KB, Terms of use)
-
(Preview, Version of record, 875.2KB, Terms of use)
-
- Publisher copy:
- 10.1371/journal.pntd.0009522
Authors
- Publisher:
- Public Library of Science
- Journal:
- PLOS Neglected Tropical Diseases More from this journal
- Volume:
- 15
- Issue:
- 7
- Article number:
- e0009522
- Publication date:
- 2021-07-08
- Acceptance date:
- 2021-06-03
- DOI:
- EISSN:
-
1935-2735
- ISSN:
-
1935-2727
- Language:
-
English
- Keywords:
- Pubs id:
-
1185685
- Local pid:
-
pubs:1185685
- Deposit date:
-
2021-07-15
Terms of use
- Copyright holder:
- Salam et al.
- Copyright date:
- 2021
- Rights statement:
- Copyright © 2021 Salam et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record